InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by REICHLING STEVEN, Chief Financial Officer. Officer active across 1 company, notably Accelerate Diagnostics, Inc. Aggregated, 9 disclosures have been recorded. Breakdown: 1 buy · 1 sell. Total volume traded: €10k. History available since 26 April 2022. The latest transaction was filed on 13 March 2023 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations9 total
9,438 shares0Common StockSEC:0001628280-23-008048:0
123,600 shares0Common StockSEC:0001628280-23-007741:0
9,439 shares0Common StockSEC:0001628280-23-003788:0
9,439 shares0Common StockSEC:0001628280-23-001133:0
4,730 shares@ US$0.6930.1% of flowCommon StockSEC:0001628280-23-001133:1
5,000 shares@ US$1.3969.9% of flowCommon StockSEC:0001628280-22-023396:0
Ideal exit: 19 May 2023 (T+270)
57,736 shares0Common StockSEC:0001628280-22-011209:0
27,392 sharesCommon StockSEC:0001628280-21-010334:0
27,392 sharesCommon StockSEC:0001628280-21-010334
9 of 9 declarations
About REICHLING STEVEN
REICHLING STEVEN serves as Chief Financial Officer at Accelerate Diagnostics, Inc. He is responsible for the financial management of the company, including budgeting, financial reporting, and funding strategy. His expertise in finance is essential for ensuring the financial health and growth of the organization.
